1995
DOI: 10.1002/gps.930100402
|View full text |Cite
|
Sign up to set email alerts
|

Treatment resistant depression in the elderly

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
1

Year Published

1995
1995
2008
2008

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 30 publications
0
4
1
Order By: Relevance
“…In line with other reports (Musetti et al, 1989;Stage, 1997;Oxman et al, 1990;Rothschild, 1996), psychosis was not signi®cantly dierent. Contrary to other reports (Jenkins et al, 1996;Reynolds III et al, 1996;Kivela, 1995;Baldwin, 1995;Bonner and Howard, 1995), chronicity and recurrences were not signi®-cantly more common in late-life depression. Many reports support a subdivision of late-life depression into early-onset and late-onset subtypes.…”
Section: Discussioncontrasting
confidence: 83%
“…In line with other reports (Musetti et al, 1989;Stage, 1997;Oxman et al, 1990;Rothschild, 1996), psychosis was not signi®cantly dierent. Contrary to other reports (Jenkins et al, 1996;Reynolds III et al, 1996;Kivela, 1995;Baldwin, 1995;Bonner and Howard, 1995), chronicity and recurrences were not signi®-cantly more common in late-life depression. Many reports support a subdivision of late-life depression into early-onset and late-onset subtypes.…”
Section: Discussioncontrasting
confidence: 83%
“…Such barriers can be categorized as patient barriers, provider barriers, conceptual barriers, and policy/funding barriers. As discussed earlier, a number of studies have documented treatment resistance among depressed older adults (e.g., Baldwin & Simpson, 1997;Bonner & Howard, 1995;Flint, 1995;Kamholz & Mellow, 1996). Besides patient and provider barriers to using psychosocial interventions, there may also be conceptual barriers as well as barriers stemming from the interrelated issues of policy, funding, and the context of treatment.…”
Section: Resultsmentioning
confidence: 97%
“…However, early in treatment, patients, their family or clinicians may mistake these somatic symptoms for side effects. Unfortunately, this often leads to premature discontinuation of antidepressant medication (Bonner and Howard, 1995;Mulsant and Pollock, 1998). In PROSPECT, the health specialists assess somatic symptoms at baseline prior to initiation of treatment and during follow-up (longitudinally) (Raue et al, 2001).…”
Section: Management Of Patients Intolerant To Treatmentmentioning
confidence: 99%